Document is current
Any future updates will be listed below
-
Authors
Palova, Hana https://orcid.org/0000-0001-8803-9433
Das, Anirban
Pokorna, Petra https://orcid.org/0000-0003-1037-878X
Bajciova, Viera
Pavelka, Zdenek
Jezova, Marta
Pal, Karol https://orcid.org/0000-0002-7726-4691
Dimayacyac, Jose R.
Negm, Logine https://orcid.org/0009-0006-9059-3824
Stengs, Lucie
Bianchi, Vanessa
Vejmelkova, Klara
Noskova, Kristyna
Jarosova, Marie
Mejstrikova, Sona
Mudry, Peter
Kyr, Michal
Merta, Tomas
Tinka, Pavel
Drabova, Klara
Aulicka, Stefania
Jugas, Robin https://orcid.org/0000-0003-4675-0985
Tabori, Uri
Slaby, Ondrej
Sterba, Jaroslav https://orcid.org/0000-0002-8482-8352
- License Information
-
More Information
Article History
Received: 20 October 2023
Accepted: 3 May 2024
First Online: 21 May 2024
Competing interests
: Ondrej Slaby: Honoraria: Roche, Bristol Myers Squibb, Consulting or Advisory Role: Roche, Bristol Myers Squibb. Jaroslav Sterba: Research Funding: Roche/Genentech (Inst) Travel, Accommodations, Expenses: BMS. The remaining authors declare no competing interests.
: Ethical approval was granted by The Ethics Committee for Multicenter Clinical Trials of the University Hospital Brno. The study was conducted in accordance with the Declaration of Helsinki. Written informed consent was provided by the parents before conducting and publishing the presented analyses.
